Acetazolamide for sleep apnea in untreated patients
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 80 years old.
- You have symptoms or a diagnosis of obstructive sleep apnea (OSA).
- You are not currently using any sleep apnea treatment, like CPAP, and agree not to start one during the study.
- You are not allergic to sulfa drugs (a type of antibiotic or other medicines).
- You do not have unstable medical conditions like heart failure, severe kidney or liver disease, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.
This trial tests a drug called DAW2020 to see if it can improve how your body controls breathing during sleep. You may qualify if you have moderate to severe sleep apnea and are otherwise healthy.
This study tests acetazolamide (a medicine that changes breathing chemistry) to see how it affects sleep quality and neurocognitive (brain/memory/attention) outcomes in adults with untreated moderate to severe sleep apnea. You may be eligible if you have significant sleep apnea but do not have certain safety risks or need to start standard sleep apnea treatment right away.
This trial tests if a drug called acetazolamide can help people with central sleep apnea who are also on medication for opioid use disorder. Sleep apnea causes breathing to stop during sleep, and this study aims to see if the drug improves their sleep breathing.
Hear when a new OSA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.